Event category: Main Stage

There has been a significant increase in the volume of data produced by patients with the litany of wearables on the market. The ability to share data between patients and providers has become easier with the advent of patient portals associated with electronic medical records. But the core question of data ownership remains—who owns these data? Data ownership is complex and important for patient empowerment. But what does the law say? Can data be co-owned by the appropriate entities involved in a patient’s care? What are the legal nuances of data ownership? And are the cybersecurity measures in place sufficient in the current state? In this session, we will start to address some of these concepts.

Cardiovascular disease is the number one killer of women. Women continue to be undertreated for cardiovascular problems compared to men, are less likely to receive bystander CPR, and are more likely to die after having a heart attack. Meanwhile, women also experience unique life events that can impact their risk, including pregnancy and menopause. The addressable market and the unmet need for cardiovascular health promotion in women is great, and yet the majority of women’s digital health funding is concentrated in maternal and reproductive health.

What are the cultural and structural barriers for developing cardiovascular digital health solutions for women? How might femtech companies increase public awareness of cardiovascular disease risk? What is the role of female representation among researchers, inventors, investors, and founders? Join incredible women leaders in tech to candidly discuss this pivotal time in women’s health innovation.

Learn from leading med tech reporters: How to capture and maintain media attention for your innovation while building effective media relationships.